Tribunal upholds surplus recognition & directs re-evaluation of ESOP disallowance per Biocon Ltd. decision

The Tribunal upheld the recognition of the surplus of Rs. 13,09,44,315/- realized from discounting the loan portfolio as income during the year, following the sale of the portfolio to commercial banks. Additionally, the Tribunal directed the Assessing Officer to re-evaluate the disallowance of Rs. 3.22 Crores related to Employee Stock Options (ESOP) in accordance with the principles outlined by the Special Bench decision in Biocon Ltd. v. DCIT, allowing the ground for statistical purposes.

---

---

Issues Involved:
1. Confirmation of surplus on value realized from the discounting of the maturity value of the loan portfolio as income during the year.
2. Disallowance of the value of Employee Stock Options (ESOP) granted and opted by employees as a business expenditure.

Issue-Wise Detailed Analysis:

1. Confirmation of Surplus on Value Realized as Income During the Year:

The primary issue is whether the surplus of Rs. 13,09,44,315/- realized from discounting the maturity value of the loan portfolio should be recognized as income during the year. The assessee, a Micro Finance Institution, sells its loan portfolios to commercial banks to obtain capital refinancing funds. The assessee amortized the gain from the future receivable interest over multiple years, arguing that the amount had not accrued up to the end of the financial year. The Assessing Officer (AO) disagreed, stating that the transaction was a complete buyout of the loan portfolio and that the entire gain should be recognized as income during the year. The Commissioner of Income Tax (Appeals) [CIT(A)] upheld this view, emphasizing that the sale of the portfolio was unconditional and that the procedures and costs involved in servicing the portfolio were irrelevant for revenue recognition.

The Tribunal examined the agreements and accounting entries, noting that the assessee received the discounted amount as part of the sale consideration, which should be recognized as income at the time of sale. The Tribunal upheld the AO's and CIT(A)'s conclusions, referencing the Madras High Court's decision in TVS Finance and Services Ltd. v. JCIT, which held that the discount on bills should be recognized as income at the time of discounting. Consequently, the Tribunal affirmed that the amount of Rs. 13,09,44,315/- should be taxable in the year it was received.

2. Disallowance of ESOP as Business Expenditure:

The second issue concerns the disallowance of Rs. 3.22 Crores, being the value of Employee Stock Options (ESOP) granted and opted by employees, which was treated as notional capital expenditure rather than business expenditure. The Tribunal referred to the Special Bench decision in Biocon Ltd. v. DCIT, which held that the difference between the market price of shares and their issue price is "expenditure" under Section 37(1) of the Income Tax Act. This expenditure is incurred when the obligation to issue shares at a discounted price arises, which is at the stage of vesting of the options, not at the grant stage. The liability is not contingent as it becomes obligatory once the service is rendered for the vesting period. The deduction should be claimed based on the period and percentage of vesting under the ESOP scheme.

The Tribunal directed the AO to work out the deduction in line with the principles laid down by the Special Bench, allowing the ground for statistical purposes.

Conclusion:

The appeal was partly allowed, with the Tribunal upholding the recognition of the discounted future interest as income during the year and directing the AO to re-evaluate the ESOP-related deduction in accordance with the Special Bench's guidelines.

---